Glaukos Corporation
GKOS
株式のランク
#1970
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
株価
$177.09
最終同期: 2026-10-21
時価総額
$10.45B
変化（1日）
1.76%
変化（1年）
131.10%
国
US
取引 Glaukos Corporation (GKOS)
カテゴリー
Healthcare
Glaukos Corporation（GKOS）の株価履歴
終値の最高値: $166.80 （2026-10-01）
終値の最安値: $29.05 （2015-06-01）
終値の最安値: $29.05 （2015-06-01）
Glaukos Corporation の株価履歴（2015 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | 16.37% |
| 2025 | -22.38% |
| 2024 | 97.91% |
| 2023 | 64.84% |
| 2022 | 1.09% |
| 2021 | -38.87% |
| 2020 | 24.29% |
| 2019 | -5.51% |
| 2018 | 133.10% |
| 2017 | -22.73% |
| 2016 | 38.93% |
| 2015 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $100.56 | -21.41% |
US
|
|
| $93.07 | -2.95% |
IE
|
|
| $297.13 | -23.49% |
US
|
|
| $44.47 | -57.18% |
US
|
|
| $46.69 | -18.50% |
DE
|
